Medindia23 小时
First FDA-Approved Mesenchymal Stromal Cell Therapy Ushers in a New Era of Regenerative ...
The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refracto ...